References
- Scott R, Robb-Smith A. Histiocyte medullary reticulosis. Lancet 1939; 2: 194–198.
- Farquhar JW, Claireaux AE. Familial haemophagocytic reticulo-sis. Arch Dis Child 1952; 27: 519–525.
- Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005: 82–88.
- Henter J-I, Söder O, Öst Å, Elinder G. Incidence and clinical features of familial hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand 1991; 80: 428–435.
- Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221–230.
- Henter JI, Elinder G, Öst Å. Diagnostic guidelines for hemopha-gocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29–33.
- Stephan JL, Zeller J, Hubert P et al. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993; 11: 451–456.
- Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of hemophagocytic lymphohistiocytosis. Br J Haematol 2001; 114: 761–769.
- Janka G, Elinder G, Imashuku S, Schneider M et al. Infection andmalignancy associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435–444.
- Fadeel B, Orrenius S, Henter J-I. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. Br J Haematol 1999; 106: 406–415.
- Fadeel B, Orrenius S, Henter J-I. Familial hemophagocytic lymphohistiocytosis: too little cell death may seriously damage your health. Leuk Lymphoma 2001; 42: 13–20.
- Prahalad S, Bove KE, Dickens D et al. Etanervept in the treatment of macrophage activation syndrome. J Rheumatol 2001; 28: 2120–2124.
- Imashuku S, Hibi S, Kuriyama K et al. Management of severe neutropenia with cyclosporine during initial treatment of epstein-barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2000; 36: 393–346.
- Francois B, Trimoreau F, Vignon P et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997; 103: 114–120.
- Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135: 299–314.
- Imashuku S, Hibi S, Sako M et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemopha-gocytic lymphohistiocytosis. Blood 1995; 86: 4706–4707.
- Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet 2006; 367: 870–873.
- To KF, Chan PK, Chan KF et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63: 242–246.
- Lee DCVV, Cheung CY, Law AHY et al p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H51\11. J Virol 2005; 79: 10147–10151.